Genfit: Under The Radar Biotech With Upcoming Catalysts (NASDAQ:GNFT)

Date:


Closeup of bubbles in water, background of cosmetic essence, serum in microscope

IRA_EVVA/iStock via Getty Images

Genfit S.A. (NASDAQ:GNFT) is gearing up for two regulatory decisions in the coming months. The FDA and European Medicines Agency [EMA] had both accepted regulatory filings of elafibranor for the treatment of patients with primary biliary



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

BITX Falls Short: Sell Recommendation Based On Risk, Cost, And Performance Analysis

Over the course of the 1-year period,...

Kevin Hartz’s A* raises its second oversubscribed fund in three years

Venture firms raised $9.3 billion in Q1 according...

When to see the Full Moon and phases

A composite image showing the Full Moons in...